Clinical Trial: Early Parkinson's Disease Monotherapy With CVN424
Study Status: COMPLETED
Recruit Status: COMPLETED
Condition: Parkinson's Disease
Study Type: INTERVENTIONAL
Official Title: A Randomized, Double-Blind, Placebo-Controlled Trial of CVN424 in Early Parkinson's Disease
Brief Summary:
This is a multicenter, 12-week, placebo-controlled clinical trial of CVN424 150 milligrams (mg) tablets in early, untreated Parkinson's Disease (PD).Participants will be randomized in a 1:1 ratio to CVN424 150 mg or placebo at the Baseline Visit.The purpose of this study is to measure effect on motor features with CVN424 tablets compared to placebo in early, untreated PD and to evaluate the potential of CVN424 to improve motor and non-motor functions in participants with early PD who are not taking…
Read more